Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: A multicentre, randomised, placebo-controlled phase 3 study

dc.contributor.author	Cappuzzo, Federico
dc.contributor.author	Ciuleanu, Tudor
dc.contributor.author	Stelmakh, Lilia
dc.contributor.author	Esteban González, Emilio
dc.date.accessioned	2013-01-30T10:21:19Z
dc.date.available	2013-01-30T10:21:19Z
dc.date.issued	2010
dc.identifier.citation	The Lancet Oncology, 11(6), p. 521-529 (2010); doi:10.1016/S1470-2045(10)70112-1	spa
dc.identifier.issn	1470-2045
dc.identifier.uri	http://hdl.handle.net/10651/10868
dc.description.statementofresponsibility	Cappuzzo, F., Ciuleanu, T., Stelmakh, L., Cicenas, S., Szczésna, A., Juhász, E., Esteban, E., Molinier, O., Brugger, W., Melezínek, I., Klingelschmitt, G., Klughammer, B., Giaccone, G.
dc.format.extent	p. 521-529	spa
dc.language.iso	eng
dc.relation.ispartof	The Lancet Oncology	spa
dc.rights	(c) The Lancet Oncology
dc.source	Scopus	spa
dc.source.uri	http://www.scopus.com/inward/record.url?eid=2-s2.0-77953541527&partnerID=40&md5=a779efb4c6cc9b6bd2c07d0c4382c7ee
dc.title	Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: A multicentre, randomised, placebo-controlled phase 3 study	spa
dc.type	journal article
dc.identifier.local	20100884	spa
dc.identifier.doi	10.1016/S1470-2045(10)70112-1
dc.relation.publisherversion	http://dx.doi.org/10.1016/S1470-2045(10)70112-1	spa

Files in this item

Files	Size	Format	View
There are no files associated with this item.